Joah Aliancy
Glaucoma Specialist · Port Orange, FLNPI 1083155295
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $6,239 of the $7,125 with a category attached, or 87.6%. It is spread thinly across 16 manufacturers, the largest accounting for just 23.8% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $5,042, more than ten times the $16 reported in 2021.
Across 132 payments — averaging $53.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lumenis BE Inc$2K
- Glaukos Corporation$1K
- AbbVie$1K
- Alcon$1K
- Sight Sciences, Inc.$615
- NEW World Medical,inc.$342
- plus $607 from 10 others
What the payments were for
- Consulting fees$82512%
- Food & beverage$6,23988%
- Education$621%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lumenis BE Inc | 1 | $1,698 |
| Glaukos Corporation | 12 | $1,471 |
| AbbVie | 47 | $1,366 |
| Alcon | 33 | $1,026 |
| Sight Sciences, Inc. | 8 | $615 |
| NEW World Medical,inc. | 9 | $342 |
| Rayner Intraocular Lenses Limited | 4 | $124 |
| Ocular Therapeutix, Inc. | 6 | $123 |
| Oyster Point Pharma, Inc. | 2 | $92 |
| Bausch & Lomb Americas Inc. | 4 | $87 |
| Harrow Eye, LLC | 1 | $73 |
| Biotissue Holdings Inc. | 1 | $33 |
| Tarsus Pharmaceuticals, Inc. | 1 | $29 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $16 |
| Ziemer USA | 1 | $15 |
| Lumibird Medical Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- M22$1,698
- OMNI(R) SURGICAL SYSTEM (US)$543
- XEN GLAUCOMA TREATMENT SYSTEM$388
- Kahook Dual Blade$261
- Clearpath$261
- Ahmed Glaucoma Valve$261
- Streamline$261
- Via360$261
- DURYSTA$250
- iDoseTR$173
- Rocklatan$148
- Rhopressa$148
- SIMBRINZA$148
- iDose$141
- Hydrus Microstent$139
- Voyager DSLT$139
- Unity$135
- iStent inject W$126
- IACCESS$126
- Clareon PanOptix Pro$125
How this compares
$7,125 in reported general payments places this provider in the 75th percentile of 31 glaucoma specialist providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LumiganBimatoprost | 71 | $36,431 |
| RestasisCyclosporine | 21 | $17,818 |
| RhopressaNetarsudil Mesylate | 46 | $16,325 |
| Prednisolone Acetate | 522 | $15,543 |
| RocklatanNetarsudil Mesylat/Latanoprost | 28 | $12,574 |
| SimbrinzaBrinzolamide/Brimonidine Tart | 35 | $9,188 |
| CombiganBrimonidine Tartrate/Timolol | 20 | $7,886 |
| Latanoprost | 559 | $7,783 |
| VyzultaLatanoprostene Bunod | 16 | $7,147 |
| Methazolamide | 13 | $6,201 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 415 | $5,845 |
| Alphagan PBrimonidine Tartrate | 14 | $4,420 |
| Brimonidine Tartrate | 229 | $3,930 |
| Ketorolac Tromethamine | 154 | $3,605 |
| MoxifloxacinMoxifloxacin Hcl | 144 | $3,417 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieLumigan, Restasis, Combigan, Alphagan P | $1,366 | $66,554126 claims |
| AlconSimbrinza | $1,026 | $9,18835 claims |
| Bausch & Lomb Americas Inc.Vyzulta | $87 | $7,14716 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 31 glaucoma specialist providers in Florida.
Other glaucoma specialist in Port Orange
- Analisa ArosemenaMiami Beach$438K
- Steven VoldWinter Garden$413K
- Matthew BrinkPalm Beach Gardens$159K
- David GreenfieldMiami$32K
- Mark WernerDelray Beach$24K
- Dan ArreazaHialeah$9K
- Daniel JewelewiczDelray Beach$9K
- Phil AlabataCrestview$7K
- Clinton SheetsHudson$7K
- Norman LevyGainesville$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.